On February 10, 2020, Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (stock abbreviation: Cheng Yi Pharmaceutical, stock code: 603811) donated 1 million yuan of anti epidemic materials to Zhejiang Charity Federation, including 600000 yuan in cash and 400000 yuan of ribavirin injection solution for diagnosis and treatment of novel coronavirus, and entrusted Intime Pharmaceutical to distribute them.
After the outbreak of the COVID-19, as the first listed marine biological pharmaceutical company in Zhejiang Province, Cheng Yi Pharmaceutical actively assumed social responsibility and took advantage of its resource accumulation and technical advantages in the pharmaceutical industry to deeply participate in the prevention and control of the COVID-19.
During the Spring Festival, Cheng Yi Pharmaceutical urgently resumed work and arranged for the production of antiviral drugs, including injections and capsules, mainly 5ml of ribavirin injection. At present, the daily production of Cheng Yi Pharmaceutical ribavirin 5ml injection can reach 300000 units, and the daily production of capsules can reach 260000 units. The production of drugs will mainly be used to reinforce key epidemic areas such as Wuhan and support the front line of epidemic prevention.
In addition, Cheng Yi Pharmaceutical also vigorously carried out anti epidemic work in terms of employee care and safety production, and on February 5, a hundred people disinfection drill was held to ensure that every employee and working environment were "disinfection and sterilization" in place. Cheng Yi Pharmaceutical stated that since the production of ribavirin drugs in Wuhan on January 27th, every person entering the company must undergo "six necessary inspections, three-level temperature measurement, independent prevention and control, and seven inquiries". Inspectors must strictly and thoroughly review each person to ensure that no one is missed or left a blind spot.
According to relevant information, Cheng Yi Pharmaceutical may have other products that may be used in the fight against the epidemic, including vitamin C injection, lincomycin hydrochloride injection, and amikacin sulfate injection. The reason for the donation of ribavirin this time is that the drug was included in the antiviral treatment part of the fifth version of the national diagnosis and treatment plan for COVID-19, while Cheng Yi Pharmaceutical said that the production of other drugs would be arranged according to the needs of the epidemic.